CollPlant Biotechnologies (CLGN) Net Margin (2017 - 2026)
CollPlant Biotechnologies (CLGN) reported Net Margin of -4242.47% for the quarter ended Mar 30, 2026, down 4171.81 percentage points from -70.66% a year earlier but up 1102.53 percentage points from the prior quarter.
CollPlant Biotechnologies (CLGN) Net Margin (2017 - 2026) Analysis & Trends
Over the twelve months ended Mar 30, 2026, CollPlant Biotechnologies' Net Margin came in at -1655.53%, down 1435.22 percentage points year-over-year; for the year ended Dec 31, 2025, it was -484.56%, up 2740.49 percentage points from the prior year.
- Net Margin has a five-year change of -390.48 percentage points (years ended Dec 2020 to Dec 2025).
- By year, Net Margin came in at -3225.05% in the year ended Dec 31, 2024 (-3161.00 pp), -64.05% in the year ended Dec 31, 2023 (+5596.49 pp), -5660.54% in the year ended Dec 31, 2022 (-5662.05 pp) and 1.52% in the year ended Dec 31, 2021 (+95.60 pp).
- Five-year quarterly Net Margin spans a low of -108150.00% in the quarter ended Sep 30, 2024 and a high of 4280.61% in the quarter ended Mar 31, 2024.
- Year over year, Net Margin gained in three of the last eight quarters, with an average year-over-year change of -603.86 percentage points.
- The high point for year-over-year Net Margin in five years was the quarter ended Sep 30, 2025 (a gain of 103626.62 percentage points); the low point was the quarter ended Sep 30, 2024 (a drop of 97970.93 percentage points).
- Per Business Quant data, the three quarters before the quarter ended Mar 30, 2026 came in at -5345.00% (quarter ended Dec 31, 2025), -4523.38% (quarter ended Sep 30, 2025) and 1869.83% (quarter ended Jun 30, 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 655.56 Bn | 574.09 Bn | 17.26 Bn | 21.86% |
| 2 | AbbVie | 470.94 Bn | 444.10 Bn | 12.70 Bn | 21.27% |
| 3 | Merck | 367.14 Bn | 321.57 Bn | 12.21 Bn | -8.04% |
| 4 | Novartis Ag | 280.33 Bn | 236.20 Bn | 11.24 Bn | 22.61% |
| 5 | Astrazeneca | 257.78 Bn | 231.34 Bn | 12.86 Bn | 18.81% |
| 6 | Amgen | 226.04 Bn | 181.44 Bn | 7.24 Bn | 23.62% |
| 7 | Gilead Sciences | 188.89 Bn | 163.01 Bn | 6.22 Bn | -134.51% |
| 8 | Pfizer | 163.75 Bn | 110.70 Bn | 10.94 Bn | -1.65% |
| 9 | Vertex Pharmaceuticals | 133.68 Bn | 105.69 Bn | 2.84 Bn | 32.99% |
| 10 | CollPlant Biotechnologies | 4.95 Mn | 4.95 Mn | -243,000.00 | -4,242.47% |
Historic Data
| Date | Value |
|---|---|
| Mar 30, 2026 | -4,242.47% |
| Dec 31, 2025 | -5,345.00% |
| Sep 30, 2025 | -4,523.38% |
| Jun 30, 2025 | 1,869.83% |
| Mar 30, 2025 | -70.66% |
| Dec 31, 2024 | -2,364.63% |
| Sep 30, 2024 | -108,150.00% |
| Jun 30, 2024 | 1,690.76% |
| Mar 31, 2024 | 4,280.61% |
| Dec 31, 2023 | -1,568.23% |
| Sep 30, 2023 | -10,179.07% |
| Jun 30, 2023 | 56.58% |
| Mar 31, 2023 | 857.97% |
| Dec 31, 2022 | -7,587.93% |
| Sep 30, 2022 | -4,017.43% |
| Jun 30, 2022 | -6,492.42% |
| Dec 31, 2021 | -1,216.77% |
| Sep 30, 2021 | -2,197.86% |
| Jun 30, 2021 | -439.65% |
| Mar 31, 2021 | 69.82% |
CollPlant Biotechnologies Net Margin API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=net-margin&ticker=CLGN&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "net-margin", "ticker": "CLGN", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=net-margin&ticker=CLGN&period=max&api_key=YOUR_API_KEY");
const data = await res.json();